21
results
for author:"Foote S.J."
in Literature Citations
| Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. van der Walt A., Stankovich J., Bahlo M., Taylor B.V., van der Mei I.A., Foote S.J., Kilpatrick T.J., Rubio J.P., Butzkueven H. Neurology 73:1018-1025(2009) · Mapped (5) |
| HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. ANZgene Consortium Tissue Antigens 74:17-21(2009) · Mapped (458) |
| Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus. Perera D., Stankovich J., Butzkueven H., Taylor B.V., Foote S.J., Kilpatrick T.J., Rubio J.P. J. Neuroimmunol. 211:105-109(2009) · Mapped (22) |
| Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. McMorran B.J., Marshall V.M., de Graaf C., Drysdale K.E., Shabbar M., Smyth G.K., Corbin J.E., Alexander W.S., Foote S.J. Science 323:797-800(2009) · Mapped (2) |
| Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutant. Rank G., Sutton R., Marshall V., Lundie R.J., Caddy J., Romeo T., Fernandez K., McCormack M.P., Cooke B.M., Foote S.J. et al. Blood 113:3352-3362(2009) · Mapped (4) |
| A Cav3.2 T-type calcium channel point mutation has splice-variant-specific effects on function and segregates with seizure expression in a polygenic rat model of absence epilepsy. Powell K.L., Cain S.M., Ng C., Sirdesai S., David L.S., Kyi M., Garcia E., Tyson J.R., Reid C.A., Bahlo M. et al. J. Neurosci. 29:371-380(2009) · Mapped (8) |
| Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Rubio J.P., Stankovich J., Field J., Tubridy N., Marriott M., Chapman C., Bahlo M., Perera D., Johnson L.J., Tait B.D. et al. Genes Immun. 9:624-630(2008) · Mapped (22) |
| Decreases in HCN mRNA expression in the hippocampus after kindling and status epilepticus in adult rats. Powell K.L., Ng C., O'Brien T.J., Xu S.H., Williams D.A., Foote S.J., Reid C.A. Epilepsia 49:1686-1695(2008) · Mapped (2) |
| The complete genome sequence of Actinobacillus pleuropneumoniae L20 (serotype 5b). Foote S.J., Bosse J.T., Bouevitch A.B., Langford P.R., Young N.M., Nash J.H.E. J. Bacteriol. 190:1495-1496(2008) · UniProtKB (2,004) |
| SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Burfoot R.K., Jensen C.J., Field J., Stankovich J., Varney M.D., Johnson L.J., Butzkueven H., Booth D., Bahlo M., Tait B.D. et al. Tissue Antigens 71:42-50(2008) · Mapped (1,235) |
| Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients. Rubio J.P., Bahlo M., Stankovich J., Burfoot R.K., Johnson L.J., Huxtable S., Butzkueven H., Lin L., Taylor B.V., Speed T.P. et al. Immunogenetics 59:177-186(2007) · Mapped (690) |
| PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain. Cook W.D., McCaw B.J., Herring C., John D.L., Foote S.J., Nutt S.L., Adams J.M. Blood 104:3437-3444(2004) · Mapped (2) |
| Analysis of 15 primary open-angle glaucoma families from Australia identifies a founder effect for the Q368STOP mutation of myocilin. Baird P.N., Craig J.E., Richardson A.J., Ring M.A., Sim P., Stanwix S., Foote S.J., Mackey D.A. Hum. Genet. 112:110-116(2003) · Mapped (9) |
| An ethyl-nitrosourea-induced point mutation in phex causes exon skipping, x-linked hypophosphatemia, and rickets. Carpinelli M.R., Wicks I.P., Sims N.A., O'Donnell K., Hanzinikolas K., Burt R., Foote S.J., Bahlo M., Alexander W.S., Hilton D.J. Am. J. Pathol. 161:1925-1933(2002) · Mapped (5) |
| Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic mice. Symons R.C., Daly M.J., Fridlyand J., Speed T.P., Cook W.D., Gerondakis S., Harris A.W., Foote S.J. Proc. Natl. Acad. Sci. U.S.A. 99:11299-11304(2002) · Mapped (5) |
| Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Rubio J.P., Bahlo M., Butzkueven H., van Der Mei I.A., Sale M.M., Dickinson J.L., Groom P., Johnson L.J., Simmons R.D., Tait B. et al. Am. J. Hum. Genet. 70:1125-1137(2002) · Mapped (690) |
| Progenitor cell mobilization by granulocyte colony-stimulating factor controlled by loci on chromosomes 2 and 11. Hasegawa M., Baldwin T.M., Metcalf D., Foote S.J. Blood 95:1872-1874(2000) · Mapped (4) |
| Structure of the RESA gene of Plasmodium falciparum. Favaloro J.M., Coppel R.L., Corcoran L.M., Foote S.J., Brown G.V., Anders R.F., Kemp D.J. Nucleic Acids Res. 14:8265-8277(1986) · UniProtKB (1) |
| Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Cowman A.F., Morry M.J., Biggs B.A., Cross G.A.M., Foote S.J. Proc. Natl. Acad. Sci. U.S.A. 85:9109-9113(1988) · UniProtKB (1) |
| Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Foote S.J., Thompson J.K., Cowman A.F., Kemp D.J. Cell 57:921-930(1989) · UniProtKB (1) |
| Amplification of the multidrug resistance gene pfmdr1 in Plasmodium falciparum has arisen as multiple independent events. Triglia T., Foote S.J., Kemp D.J., Cowman A.F. Mol. Cell. Biol. 11:5244-5250(1991) · UniProtKB (1) |
